Online Program

327127
A statewide linkage to HIV medical care initiative in North Carolina


Sunday, November 1, 2015

Kristen Sullivan, PhD, MSW, MA, Center for Health Policy and Inequalities Research, Duke University, Durham, NC
Jenna Donovan, MPH, Communicable Disease Branch, N.C. Department of Health and Human Services, Raleigh, NC
Evelyn Byrd Quinlivan, M.D., Institute for Global Health and Infectious Diseases; UNC Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, NC
Renee Jensen, BS, Center for Health Policy and Inequalities Research, Duke University, Durham, NC
Donna Safley, MPS, Center for Health Policy and Inequalities Research, Duke University, Durham, NC
Heather Parnell, MSW, Center for Health Policy and Inequalities Research, Duke University, Durham, NC
Miriam Berger, MPH, Center for Health Policy and Inequalities Research, Duke University, Durham, NC
Victoria Mobley, MD, MPH, N.C. Department of Health and Human Services, Raleigh, NC
Jacquelyn Clymore, MS, Communicable Disease Branch, North Carolina Department of Health and Human Services, Raleigh, NC
background: Timely linkage to HIV care is associated with improved clinical outcomes and retention-in-care. Linkage services incorporating strengths-based counseling, HIV education and systems navigation support were provided by public health service employees (State Bridge Counselors, SBCs) to newly-diagnosed people living with HIV/AIDS (PLWHA) who failed to attend first HIV medical appointments. This study describes the demographics of patients receiving linkage services, client needs addressed, and linkage-to-care outcomes.

methods: SBC intervention tracking data from CAREWare were utilized. Linkage clients’ records from July 2013 to June 2014 were analyzed. Descriptive statistics were calculated on patient demographics, services provided, and outcomes. Data collection and analyses are ongoing.

results: Ninety-four newly diagnosed PLWHA were referred for SBC linkage services, out of 1509 (preliminary number) new diagnoses during this period.  Of those referred, 75(79.8%) were male and 63(67.0%) were black/African American. Forty-four patients received SBC linkage services (direct or indirect), addressing 172 identified specific needs. Medically-related needs (providing education or appointment scheduling) were the most common (n=86, 50.0%); barriers-to-care most commonly addressed among this group were transportation (n=43,25.0%), insurance/benefits (n=36,20.9%), and other financial barriers (n=27,15.7%). Outcomes for referrals included: 37(39.3%) engaged in care; 18 (19%) were not located; 8 (8.5%) were located and did not enter care; and 6(6.3%) moved out-of-state [missing data=17(18.1%)].

conclusions: Nearly 40% of patients referred for linkage services were engaged in medical care, suggesting the SBC linkage program may be beneficial for this hard-to-engage population. Additional patient search mechanisms should be explored to enhance the reach and impact of this intervention.

Learning Areas:

Conduct evaluation related to programs, research, and other areas of practice
Protection of the public in relation to communicable diseases including prevention or control
Public health or related research
Social and behavioral sciences

Learning Objectives:
Explain the importance of timely linkage to medical care for newly diagnosed PLWHA. 2Describe the patients referred to SBC linkage services, services provided, and outcomes of the intervention. Discuss implications of these findings for developing linkage-to-care interventions.

Keyword(s): HIV/AIDS, HIV Interventions

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the Evaluator and Duke site PI for the NC-LINK project. I have significant experience designing and implementing evaluations of interventions to increase engagement in HIV care.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 2031.0: HIV/AIDS Care